Dual inhibition of MET and SRC kinase activity as a combined targeting strategy for colon cancer

Hepatocyte growth factor (HGF)/MET signaling is implicated in the development of colorectal cancer (CRC) and possesses therapeutic value for various types of cancer. However, inhibition of MET alone has been demonstrated to have limited efficacy. The present study examined the combined inhibition of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Exp Ther Med
Autors principals: Song, Na, Qu, Xiujuan, Liu, Shizhou, Zhang, Simeng, Liu, Jing, Qu, Jinglei, Zheng, Huachuan, Liu, Yunpeng, Che, Xiaofang
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2017
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5526150/
https://ncbi.nlm.nih.gov/pubmed/28810597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.4692
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars